We found that tumours of ibrutinib-treated mice expressed significantly lower transcripts of Vegf (Fig. 2e), Mmp9 (Fig. 2f), and Cxcl1 (Fig. 2g) compared to tumours of the vehicle-treated group. Here, CXCL1 is linked to neoplasm.